Survival Analysis of Pathological T3a Upstaging in Clinical T1 Renal Cell Carcinoma

Aim: To evaluate the oncological outcomes of pathological T3a upstaging from clinical T1 renal cell carcinoma. Patients and Methods: We retrospectively studied patients who underwent radical or partial nephrectomy for clinical T1 renal tumors. Results: The median follow-up period was 44 months. At t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:In Vivo
Main Authors: LAI, GU-SHUN, LI, JIAN-RI, WANG, SHIAN-SHIANG, CHEN, CHUAN-SHU, YANG, CHUN-KUANG, HUNG, SHENG-CHUN, CHENG, CHEN-LI, OU, YEN-CHUAN, CHIU, KUN-YUAN
Formato: Artigo
Idioma:Inglês
Publicado em: International Institute of Anticancer Research 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7157890/
https://ncbi.nlm.nih.gov/pubmed/32111787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11841
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados